Meusinvest (Noshaq) logo

Meusinvest (Noshaq)

Europe, Liege, Belgium, Liège

Description

Noshaq, formerly known as Meusinvest, stands as a pivotal financial partner dedicated to fostering economic growth within the Liège region of Belgium. With a rich history spanning over 35 years, the organization has consistently provided diverse financing solutions to businesses, ranging from nascent startups to established enterprises undergoing expansion or ownership transitions. Their strategic objective is to support the local economy by offering tailored investment vehicles, including equity, subordinated loans, and convertible loans, across various stages of a company's lifecycle.

The firm's investment scope is broad, encompassing seed and start-up funding, growth and development capital, management buy-outs (MBOs) and buy-ins (MBIs), and even real estate projects. For early-stage and innovation-focused ventures, Noshaq typically deploys initial investments ranging from €50,000 to €500,000. However, for more mature companies seeking growth capital or undergoing transmission, their interventions can extend from €250,000 up to several million euros, often participating in co-investment rounds to facilitate larger capital injections.

Noshaq boasts an impressive track record, having invested in more than 480 companies throughout its operational history. This extensive portfolio underscores its commitment to the regional business ecosystem. Collectively, the companies within Noshaq's portfolio contribute significantly to the local economy, generating a substantial €4.6 billion in turnover and supporting approximately 15,000 jobs. The organization's long-standing presence and flexible investment approach make it a key player in the Belgian venture and growth capital landscape, particularly for businesses rooted in the Liège area.

Investor Profile

Meusinvest (Noshaq) has backed more than 71 startups, with 6 new investments in the last 12 months alone. The firm has led 6 rounds, about 8% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium, France, Germany.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $54K – $5.4M.

Stage Focus

  • Series A (30%)
  • Seed (27%)
  • Series Unknown (18%)
  • Series B (14%)
  • Series D (3%)
  • Convertible Note (1%)
  • Undisclosed (1%)
  • Series C (1%)
  • Series E (1%)
  • Pre Seed (1%)

Country Focus

  • Belgium (66%)
  • France (21%)
  • Germany (4%)
  • United Kingdom (3%)
  • United States (1%)
  • Luxembourg (1%)
  • Switzerland (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
  • Manufacturing
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Sports
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Meusinvest (Noshaq) frequently co-invest with?

G
Europe, Liege, Belgium, Liège
Co-Investments: 4
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 4
The Faktory Fund
Europe, Liege, Belgium, Liège
Co-Investments: 5
Spreds
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 5
Investsud
Europe, Luxembourg, Belgium, Marche-en-famenne
Co-Investments: 5
Inventures SA
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 4
LeanSquare
Europe, Liege, Belgium, Liège
Co-Investments: 7
WING by Digital Wallonia
Europe, Liege, Belgium, Liège
Co-Investments: 6
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 10
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 8

Which angels does Meusinvest (Noshaq) often collaborate with?

BC
Europe, Limburg, Belgium
Shared Deals: 1
SL
Europe, Austria
Shared Deals: 1
MK
Europe, Nord-Pas-de-Calais, France, Lille
Shared Deals: 1
AS
Europe, Austria
Shared Deals: 1
AV
Europe, Antwerpen, Belgium, Antwerp
Shared Deals: 1
OK
Europe, Niedersachsen, Germany, Hanover
Shared Deals: 1
Shared Deals: 1
JV
Europe, England, United Kingdom, London
Shared Deals: 1
KB
North America, New York, United States, New York
Shared Deals: 1
PR
Europe, Liege, Belgium, Ougrée
Shared Deals: 2

What are some of recent deals done by Meusinvest (Noshaq)?

Le Fourgon

Marquette Lez Lille, Nord-Pas-de-Calais, France

Le Fourgon offers milk, water, beer, wine, fruit juice, and sodas.

Food and BeverageHospitality
Series AJan 30, 2025
Amount Raised: $5,900,000
TrustUp

Leuven, Vlaams-Brabant, Belgium

TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.

E-CommerceInternetReal Estate
Series AJan 1, 2025
Amount Raised: $5,175,469
Veoware

Guilford, Surrey, United Kingdom

Veoware provides Space satellite imagery services.

Satellite Communication
Series UnknownSep 19, 2024
Amount Raised: $2,789,867
Brenus Pharma

Issoire, Auvergne, France

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

BiotechnologyPharmaceutical
Series ASep 18, 2024
Amount Raised: $25,000,000

Manufacture of computer and electronic products

Series UnknownAug 28, 2024
Amount Raised: $945,582
Hedera-22

Liège, Liege, Belgium

R&D of innovative products based on the use of new natural molecules

Biotechnology
Series UnknownAug 14, 2024
Amount Raised: $2,204,875
SamanTree Medical

Lausanne, Vaud, Switzerland

SamanTree Medical is an innovative Swiss company, developing a medical device to acquire tissue images during surgical cancer intervention.

BiotechnologyHealth CareHealth DiagnosticsInformation TechnologyMedical
Series BJul 16, 2024
Amount Raised: $14,000,000
MYOCENE

Liège, Liege, Belgium

Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.

Medical DeviceSports
SeedJun 18, 2024
Amount Raised: $3,217,793
Novobiom

Louvain-la-neuve, Vlaams-Brabant, Belgium

Bioremediation for persistant and pervasive pollutants

SeedMay 1, 2024
Amount Raised: $2,143,574
CryoTherapeutics

Potsdam, Brandenburg, Germany

CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system.

BiotechnologyClinical TrialsHealth CareMedicalTherapeutics
Series BApr 2, 2024
Amount Raised: $10,768,180